Our novel results demonstrate that DUSP28 plays a pivotal role in pancreatic cancer malignancy, suggesting that targeting DUSP28 might be a smart strategy for blocking pancreatic cancer. This evidence concerns the gene DUSP28 and pancreatic neoplasm.